Kidney disease means your kidneys are damaged and can’t filter blood the way they should. Those with diabetes or high blood pressure are at greater risk of developing kidney disease.
Kidney problems include acute kidney injury, chronic kidney disease, kidney cysts, kidney stones, and kidney infections.
Kidney International has published the "International Society of Nephrology First Consensus Guidance for Pre-clinical Animal Studies in Translational Nephrology." The paper was developed from the First Consensus Meeting on Guidance for Optimal Pre-Clinical Animal Studies in Translational Nephrology (TRANSFORM) hosted by the ISN in Brussels, Belgium, in October 2022. Pre-clinical tests in animal models are key steps in...
The 2023 Board Review CME and Contemporary Issues in Nephrology meeting will take place in a hybrid format in Beijing, China, from April 14-16, 2023. ISN Past President Agnes Fogo’s pre-recorded opening welcome and two presentations will be broadcast on Friday, April 14, Beijing time (convert to your time zone here). Professor Fogo will be...
World Kidney Day (WKD) 2023 took place on March 9. The ISN joins WKD organizers in thanking all who supported WKD activities this year to raise awareness of the impact of disastrous events on people living with kidney disease. WKD's success relies on the inspiring efforts of healthcare professionals, patients, supporters and the public. Have your...
Watch the latest ISN video abstract from the @ISNeducation Social Media Team. Watch the video here. This video is based on a paper from Kidney International Reports: Antibody Guided Therapy In PLA2R-associated Membranous Nephropathy
The ISN is currently inviting applications for ISN Interventional Nephrology Scholarships. The deadline to apply is June 1, 2023. Start your application here. These short courses offer training in interventional nephrology procedures to ISN members from low- and middle-income countries. Successful applicants will train in CVC placement, PD catheter insertion, kidney biopsy, and endovascular procedures at ISN...
Members of the African Association of Nephrology (AFRAN) and the ISN Advocacy team collaborated for over a year to finalize the declaration designed to help advocate for better kidney health in Africa. Access the declaration here. "The Abidjan Declaration in Support of Kidney Care in the African Continent" was launched during the AFRAN's 2023 congress in...
The course will take place in a virtual format from March 22-24, 2023. It is hosted by the Department of Renal Medicine, Royal Free Hospital/University College London, in London, UK, which is currently part of an ISN Sister Renal Centers partnership. On Wednesday, March 22, ISN President Agnes Fogo’s recorded keynote lecture, "The Role of...
Seven finalists have been selected from twenty-eight entries to compete for the “2023 ISN Film Community Best Film.” Cast your vote here! The finalists are: Overcoming the Remoteness With Love for a Kidney Transplantation Hidden CKD: Patient's Perspectives Enduring Hope: The Story of Dr. Akos Petho Research Provides Hope for Transplant Patients Unconditional Love Miracles Happen Every Day Hope Sustains Life: Through the Lens...
The ISN Sister Renal Centers (SRC) Program Committee is pleased to announce that 11 new partnerships have been accepted into the ISN Sister Renal Centers (SRC) Program. These newly formed partnerships were selected based on the emerging center's local kidney health needs and the potential to develop kidney care capacity and services for people with...
Please join us in congratulating the 2023 ISN Pioneer Award winners from eight different ISN regions: Africa: Professor Emeritus Adewale Akinsola (Nigeria) Eastern and Central Europe: Professor Goce Spasovski (Macedonia) Latin America: Dr. Juan Abraham Bermúdez (Mexico) Middle East: Mohammad Ali Ghnaimat (Jordan) Newly Independent States and Russia: Irma Tchokhonelidze (Georgia) North America and the Caribbean: Merle...
In February, the ISN delivered a one-and-a-half-day "Nephrology for the Non-nephrologist," course for primary care physicians in New Delhi. One hundred participants attended the event. The ISN provided the course content, the development of which was led by Umesh Khanna and Mayuri Trivedi and presented by 26 faculty. Participants can now continue this complimentary course and...
In February, the ISN delivered five "Grand Rounds" sessions, "Advanced Topics in Nephrology," in four major cities in India. The sessions were led by Roberto Pecoits-Filho and Sri Lekha Tummalapelli and supported by experts from each city to ensure local relevance. The content included new and upcoming advances in chronic kidney disease identification, optimal management of...
Emerging Leaders Program member, Robert Kalyesubula Robert Kalyesubula (Uganda) joined the inaugural ISN Emerging Leaders Program (ELP) cohort in 2021. He recently featured in an article in The Guardian as the pioneer behind a successful local healthcare program in Uganda, the Balamu project, launched to tackle non-communicable diseases (NCDs) in the region. Read the newspaper article...
The ISN and The Transplantation Society (TTS) are pleased to announce that four newly formed partnerships have been accepted into the joint ISN-TTS Sister Transplant Centers (STC) Program. In addition, one partnership has successfully upgraded to Level A and four partnerships to Level B. One partnership has successfully graduated. The Southern Philippines Medical Center Kidney Transplant...
The next #NephTrials will be held on March 10, 2023, at 3 p.m. CET! Join Ron Gansevoort, primary investigator of the RENAL LIFECYCLE trial, in conversation with Michael Walsh, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath. The panel will examine the composite and secondary outcomes of a randomized control trial investigating the effects...
Kidney International: Results From Part A of the Multi-center, Double-blind, Randomized, Placebo-controlled Nefigard Trial, Which Evaluated Targeted-release Formulation of Budesonide for the Treatment of Primary Immunoglobulin A Nephropathy To verify the findings of the 2b NEFIGAN trial, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon® versus placebo...
An editorial by ISN President Professor Agnes Fogo has been published in the winter edition of the Journal of the American Association of Physicians of Indian Origin (JAAPI). Read the open-access article here. "Kidney Disease: The Silent Killer That Needs Our Voice" includes the most recent data on the burden of kidney disease, raising awareness of...
Two classic films are now available to watch on the ISN Academy: "The Human Kidney: Tubules, Blood Vessels and Vascular-Tubular Relations" and "The Vascular and Tubular Organization of the (Dog) Kidney" These historical, yet clinically still relevant, films were independently produced in 1975 by members of the Department of Physiology at Harvard Medical School.* They illustrate the highly...
IgA nephropathy is one of the most common glomerular diseases, worldwide. The diagnostic histologic hallmark is dominant or codominant IgA staining on kidney biopsy; however, patients may present with various clinical syndromes ranging from asymptomatic abnormalities noted on urinalysis, nephritic syndrome, nephrotic-nephritic syndrome to rapidly progressive glomerulonephritis with crescentic transformation. There is substantial heterogeneity in the...
Did you miss the live session of the ISN Webinar "Mixed Methods Research in Kidney Care"? Watch the recording here. Moderators Fergus Caskey, Pippa Bailey, and Masaomi Nangaku joined speakers Alicia O’Cathain and Lilia Cervantes in an interactive discussion on mixing qualitative and quantitative research methods within a single kidney care study. The event generated much...
